Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.

MLA

Vonderheid, Eric C., et al. “Evidence for Restricted Vbeta Usage in the Leukemic Phase of Cutaneous T Cell Lymphoma.” The Journal of Investigative Dermatology, vol. 124, no. 3, Mar. 2005, pp. 651–61. EBSCOhost, https://doi.org/10.1111/j.0022-202X.2004.23586.x.

APA

Vonderheid, E. C., Boselli, C. M., Conroy, M., Casaus, L., Espinoza, L. C., Venkataramani, P., Bigler, R. D., & Hou, J. S. (2005). Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma. The Journal of Investigative Dermatology, 124(3), 651–661. https://doi.org/10.1111/j.0022-202X.2004.23586.x

Chicago

Vonderheid, Eric C, Christine M Boselli, Michael Conroy, Laurie Casaus, Lisa Cheley Espinoza, Prakash Venkataramani, Robert D Bigler, and J Steve Hou. 2005. “Evidence for Restricted Vbeta Usage in the Leukemic Phase of Cutaneous T Cell Lymphoma.” The Journal of Investigative Dermatology 124 (3): 651–61. doi:10.1111/j.0022-202X.2004.23586.x.